Cargando…

Bortezomib in autoimmune hemolytic anemia and beyond

Bortezomib is a first-in-class, potent, selective and reversible proteasome inhibitor approved for the treatment of multiple myeloma (MM) and relapsed/refractory mantle cell lymphoma. In these diseases, bortezomib targets plasma cells and lymphocytes reducing tumor burden. Recently, preclinical evid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasquale, Raffaella, Giannotta, Juri Alessandro, Barcellini, Wilma, Fattizzo, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593301/ https://www.ncbi.nlm.nih.gov/pubmed/34795889 http://dx.doi.org/10.1177/20406207211046428

Ejemplares similares

Infectious Complications in Autoimmune Hemolytic Anemia
por: Giannotta, Juri Alessandro, et al.
Publicado: (2021)

New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
por: Barcellini, Wilma, et al.
Publicado: (2020)

Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia
por: Fattizzo, Bruno, et al.
Publicado: (2022)

The Changing Landscape of Autoimmune Hemolytic Anemia
por: Barcellini, Wilma, et al.
Publicado: (2020)

Diagnosis and Management of Autoimmune Hemolytic Anemias
por: Barcellini, Wilma, et al.
Publicado: (2022)

Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature
por: Motta, Irene, et al.
Publicado: (2021)

Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Autoimmune Complications in Hematologic Neoplasms
por: Barcellini, Wilma, et al.
Publicado: (2021)

Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The “Seed and Soil” Crosstalk
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives
por: Barcellini, Wilma, et al.
Publicado: (2019)

The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
por: Berentsen, Sigbjørn, et al.
Publicado: (2023)

Cytokine polymorphisms in patients with autoimmune hemolytic anemia
por: Zaninoni, Anna, et al.
Publicado: (2023)

Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature
por: Barcellini, Wilma, et al.
Publicado: (2021)

Secondary Hemophagocytic Lymphohistiocytosis and Autoimmune Cytopenias: Case Description and Review of the Literature
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
por: Fattizzo, Bruno, et al.
Publicado: (2021)

New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
por: Barcellini, Wilma
Publicado: (2015)

P1482: RECOMBINANT ERYTHROPOIETIN IN AUTOIMMUNE HEMOLYTIC ANEMIA WITH INADEQUATE RETICULOCYTOSIS: A SINGLE CENTER PROSPECTIVE STUDY
por: Luca Pedone, Giacinto, et al.
Publicado: (2023)

Large Granular Lymphocyte Expansion in Myeloid Diseases and Bone Marrow Failure Syndromes: Whoever Seeks Finds
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Monitoring of Patients with Autoimmune Cytopenias during Sars-Cov-2 Vaccination Campaign: The Experience of a Reference Center
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Difficult Cases of Paroxysmal Nocturnal Hemoglobinuria: Diagnosis and Therapeutic Novelties
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature
por: Giannotta, Juri Alessandro, et al.
Publicado: (2021)

P1583: TRANSFUSIONS IN AUTOIMMUNE HEMOLYTIC ANEMIA: FREQUENCY AND CLINICAL SIGNIFICANCE OF ALLOIMMUNIZATION
por: Versino, Francesco, et al.
Publicado: (2023)

Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
por: Barcellini, W., et al.
Publicado: (2015)

Seroconversion to mRNA SARS-CoV-2 vaccines in patients with autoimmune cytopenias and bone marrow failures
por: Fattizzo, Bruno, et al.
Publicado: (2022)

P1526: AUTOIMMUNE HEMOLYTIC ANEMIAS: RELATIONSHIP BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS OF CYTOKINE GENES AND CLINICAL/HEMATOLOGICAL PARAMETERS
por: Zaninoni, A., et al.
Publicado: (2022)

Efficacy and safety of cyclosporine A treatment in autoimmune cytopenias: the experience of two Italian reference centers
por: Fattizzo, Bruno, et al.
Publicado: (2022)

P1555: IRON CHELATION THERAPY IN CONGENITAL HEMOLYTIC ANEMIAS: AN ITALIAN SINGLE CENTER STUDY
por: Bosi, A., et al.
Publicado: (2022)

Severe autoimmune hemolytic anemia; epidemiology, clinical management, outcomes and knowledge gaps
por: Mulder, Femke V. M., et al.
Publicado: (2023)

Severe Presentation of Congenital Hemolytic Anemias in the Neonatal Age: Diagnostic and Therapeutic Issues
por: Cortesi, Valeria, et al.
Publicado: (2021)

Hemolytic Anemias: Autoimmune and Beyond
por: Krishnadasan, Ravi
Publicado: (2021)

Hematological and Extra-Hematological Autoimmune Complications after Checkpoint Inhibitors
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience
por: Fattizzo, Bruno, et al.
Publicado: (2023)

Novel Therapies for Unmet Clinical Needs in Myelodysplastic Syndromes
por: Cassanello, Giulio, et al.
Publicado: (2022)

Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia
por: Yao, Mingkang, et al.
Publicado: (2022)

Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Targeted Next Generation Sequencing and Diagnosis of Congenital Hemolytic Anemias: A Three Years Experience Monocentric Study
por: Fermo, Elisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9n84lteau9cfts98oltan18qdo